Fungal Antibiogram Yeast MIC Panel

The Fungal Antibiogram Yeast MIC Panel measures the minimum inhibitory concentrations (MICs) of key antifungal drugs against yeast isolates—most commonly Candida species—to determine susceptibility or resistance. Samples are collected at home by a trained technician and processed in an accredited laboratory using standardized MIC methods to guide precise therapy. This information helps clinicians in Dubai and across the UAE select effective antifungal regimens, reduce treatment failures, and support antimicrobial stewardship.

• Yeast species identification
• Fluconazole MIC
• Voriconazole MIC
• Amphotericin B MIC
• Caspofungin MIC
• Micafungin MIC

• Persistent or recurrent mucocutaneous yeast infections despite treatment
• Suspected or confirmed invasive candidiasis (e.g., bloodstream infections)
• Treatment failure or clinical relapse after antifungal therapy
• Immunocompromised patients (oncology, transplant, HIV) with suspected fungal infection
• Prior exposure to antifungals or local epidemiology suggesting resistance

• Targeted antifungal selection based on quantitative MIC results
• Identification of resistant isolates to avoid ineffective therapy
• Supports faster, evidence-based clinical decision-making
• Reduces unnecessary broad-spectrum antifungal use and adverse effects
• Convenient at-home sample collection with laboratory-grade testing

• At-home specimen collection by a trained phlebotomist or nurse (blood, swab, urine or tissue as indicated)
• Inform the team of current or recent antifungal medications; withholding systemic antifungals may be advised if clinically safe
• No fasting required; ensure the correct specimen type and container as instructed
• Specimen must reach the lab within the recommended transport timeframe for reliable culture and MIC testing